These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36538073)

  • 1. Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study.
    Wang J; Dong P; Qu Y; Xu W; Zhou Z; Ning K; Peng Y; Xiong L; Li Z; Zou X; Liu Z; Li M; He Z; Luo J; Tian X; Zhang H; Guo S; Han H; Zhou F; Yin S; Ye D; Yu C; Zhang Z
    Eur Radiol; 2023 May; 33(5):3232-3242. PubMed ID: 36538073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy.
    Ning K; Li Z; Liu H; Tian X; Wang J; Wu Y; Xiong L; Zou X; Peng Y; Zhou Z; Zhou F; Yu C; Luo J; Zhang H; Dong P; Zhang Z
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy.
    Chaunzwa TL; Qian JM; Li Q; Ricciuti B; Nuernberg L; Johnson JW; Weiss J; Zhang Z; MacKay J; Kagiampakis I; Bikiel D; Di Federico A; Alessi JV; Mak RH; Jacob E; Awad MM; Aerts HJWL
    JAMA Oncol; 2024 Jun; 10(6):773-783. PubMed ID: 38780929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab.
    McManus HD; Zhang D; Schwartz FR; Wu Y; Infield J; Ho E; Armstrong AJ; George DJ; Kruse D; Gupta RT; Harrison MR
    Clin Genitourin Cancer; 2023 Dec; 21(6):e429-e437.e2. PubMed ID: 37271698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
    Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
    Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
    Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
    Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Body Composition Parameters Measured by Computed Tomography with Cancer Stage, Prognosis, and Survival in Patients with Renal Cell Carcinoma.
    Gur Ozcan SG; Barali D; Erkan A
    Curr Med Imaging; 2024; 20(1):e15734056301569. PubMed ID: 38544394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor metabolic activity is associated with subcutaneous adipose tissue radiodensity and survival in non-small cell lung cancer.
    Sun Y; Deng M; Gevaert O; Aberle M; Olde Damink SW; van Dijk D; Rensen SS
    Clin Nutr; 2024 Jul; 43(7):1809-1815. PubMed ID: 38870661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.
    Maurits JSF; Sedelaar JPM; Mulders PFA; Aben KKH; Kiemeney LALM; Vrieling A
    Clin Nutr; 2022 Jan; 41(1):131-143. PubMed ID: 34872047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nomogram Including Sarcopenia for Predicting Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma: A Retrospective Cohort Study.
    Su W; Wu Y; Liao S; Zhang Z; Zhang Y; Ou W; Yu J; Xiang F; Luo C; Zheng F
    Ann Surg Oncol; 2024 Sep; 31(9):5815-5826. PubMed ID: 38954088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Utility of Parameters Derived From Pretreatment Dual-Layer Spectral-Detector CT in Patients With Metastatic Renal Cell Carcinoma.
    Drljevic-Nielsen A; Donskov F; Mains JR; Andersen MB; Thorup K; Thygesen J; Rasmussen F
    AJR Am J Roentgenol; 2022 May; 218(5):867-876. PubMed ID: 34910540
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
    Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
    Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series.
    Gu W; Zhu Y; Wang H; Zhang H; Shi G; Liu X; Ye D
    PLoS One; 2015; 10(2):e0118022. PubMed ID: 25668688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
    Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
    Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan.
    Pai PC; Chuang CC; Chuang WC; Tsang NM; Tseng CK; Chen KH; Yen TC; Lin CY; Chang KP; Lei KF
    Cancer Med; 2018 May; 7(5):1630-1641. PubMed ID: 29608254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-defined body composition as a prognostic factor in multiple myeloma.
    Surov A; Benkert F; Pönisch W; Meyer HJ
    Hematology; 2023 Dec; 28(1):2191075. PubMed ID: 36946869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma.
    Aslan V; Kılıç ACK; Sütcüoğlu O; Eraslan E; Bayrak A; Öksüzoğlu B; Tahtacı G; Özdemir N; Üner A; Günel N; Özet A; Yazıcı O
    Urol Oncol; 2022 Nov; 40(11):494.e1-494.e10. PubMed ID: 36137881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.
    Souza ACDAH; Rosenthal MH; Moura FA; Divakaran S; Osborne MT; Hainer J; Dorbala S; Blankstein R; Di Carli MF; Taqueti VR
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):179-191. PubMed ID: 37768241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.
    Antoun S; Lanoy E; Iacovelli R; Albiges-Sauvin L; Loriot Y; Merad-Taoufik M; Fizazi K; di Palma M; Baracos VE; Escudier B
    Cancer; 2013 Sep; 119(18):3377-84. PubMed ID: 23801109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.